Current Developments in Alzheimer's Disease and Treatment

:Alzheimer's Disease (AD) is a progressive and irreversible disease with a high incidence in older people in our country and in the world, and its pathophysiology is not fully understood. There is no definitive treatment for the disease, but some hypotheses that are thought to be effective in treatment have been determined; The most effective of these is the cholinergic hypothesis, and in this hypothesis, it was observed that Acetylcholine (Ach) levels were low in the brains of patients. Other hypotheses are the Tau and Amyloid hypothesis, and oxidative stress and neuroinflammation. Current treatments are more symptomatic, and the first drugs approved for use are the Acetylcholinesterase inhibitor (AchE) rivastigmine, galantamine, donepezil, and the NMDA receptor antagonist memantine. In the development of new treatments, pathological causes have been targeted, new methods have been tried to reduce amyloid accumulation and tau phosphorylation, and effective drugs have been found, but they have not been put into clinical use. Antioxidant compounds have been studied to suppress oxidative stress. Other treatment methods include stem cell therapy, vaccination and the use of estrogen.

Authors

Institutions

Publication Details

Journal
Anatolian Journal of Pharmaceutical Sciences
Published
2025-03-28
DOI
https://doi.org/10.71133/anatphar.1577117
Primary Topic
Cholinesterase and Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Current Developments in Alzheimer's Disease and Treatment

Semanur Kaya, İsmet Yılmaz
Anatolian Journal of Pharmaceutical Sciences
Cholinesterase and Neurodegenerative Diseases
article

Current Developments in Alzheimer's Disease and Treatment

Semanur Kaya, İsmet Yılmaz
article en

Abstract

:Alzheimer's Disease (AD) is a progressive and irreversible disease with a high incidence in older people in our country and in the world, and its pathophysiology is not fully understood. There is no definitive treatment for the disease, but some hypotheses that are thought to be effective in treatment have been determined; The most effective of these is the cholinergic hypothesis, and in this hypothesis, it was observed that Acetylcholine (Ach) levels were low in the brains of patients. Other hypotheses are the Tau and Amyloid hypothesis, and oxidative stress and neuroinflammation. Current treatments are more symptomatic, and the first drugs approved for use are the Acetylcholinesterase inhibitor (AchE) rivastigmine, galantamine, donepezil, and the NMDA receptor antagonist memantine. In the development of new treatments, pathological causes have been targeted, new methods have been tried to reduce amyloid accumulation and tau phosphorylation, and effective drugs have been found, but they have not been put into clinical use. Antioxidant compounds have been studied to suppress oxidative stress. Other treatment methods include stem cell therapy, vaccination and the use of estrogen.

Anatolian Journal of Pharmaceutical SciencesVol. 4(1)
Inonu University (TR)
Openalex Percentile: Top 93%
Cholinesterase and Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Current Developments in Alzheimer's Disease and Treatment — Semanur Kaya, İsmet Yılmaz · Anatolian Journal of Pharmaceutical Sciences (2025) | TGRS Research Map | TGRS